Aude Fourcade
EHESP
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Aude Fourcade.
BMJ Quality & Safety | 2012
Aude Fourcade; Jean-Louis Blache; Catherine Grenier; Jean-Louis Bourgain; Etienne Minvielle
Objective Implementation of a surgical checklist depends on many organisational factors and on socio-cultural patterns. The objective of this study was to identify barriers to effective implementation of a surgical checklist and to develop a best use strategy. Setting 18 cancer centres in France. Design The authors first assessed use compliance and completeness rates of the surgical checklist on a random sample of 80 surgical procedures performed under general or loco-regional anaesthesia in each of the 18 centres. They then developed a typology of the organisational and cultural barriers to effective checklist implementation and defined each barriers contents using data from collective and semi-structured individual interviews of key staff, the results of an email questionnaire sent to the 18 centres, and direct observations over 20 h in two centres. Results The study consisted of 1440 surgical procedures, 1299 checklists, and 28 578 items. The mean compliance rate was 90.2% (0, 100). The mean completion rate was 61% (0, 84). 11 barriers to effective checklist implementation were identified. Their incidence varied widely across centres. The main barriers were duplication of items within existing checklists (16/18 centres), poor communication between surgeon and anaesthetist (10/18), time spent completing the checklist for no perceived benefit, and lack of understanding and timing of item checks (9/18), ambiguity (8/18), unaccounted risks (7/18) and a time-honoured hierarchy (6/18). Conclusions Several of the barriers to the successful implementation of the surgical checklist depended on organisational and cultural factors within each centre. The authors propose a strategy for change for checklist design, use and assessment, which could be used to construct a feedback loop for local team organisation and national initiatives.
BMC Health Services Research | 2017
Chloé Gervès-Pinquié; Fatima Daumas-Yatim; Benoît Lalloué; Anne Girault; Marie Ferrua; Aude Fourcade; François Lemare; Mario DiPalma; Etienne Minvielle
BackgroundThe emergence of oral delivery in cancer therapeutics is expected to result in an increased need for better coordination between all treatment stakeholders, mainly to ensure adequate treatment delivery to the patient. There is significant interest in the nurse navigation program’s potential to improve transitions of care by improving communication between treatment stakeholders and by providing personalized organizational assistance to patients. The use of health information technology is another strategy aimed at improving cancer care coordination that can be combined with the NN program to improve remote patient follow-up. However, the potential of these two strategies combined to improve oral treatment delivery is limited by a lack of rigorous evidence of actual impact.Methods/designWe are conducting a large scale randomized controlled trial designed to assess the impact of a navigation program denoted CAPRI that is based on two Nurse Navigators and a web portal ensuring coordination between community and hospital as well as between patients and navigators, versus routine delivery of oral anticancer therapy. The primary research aim is to assess the impact of the program on treatment delivery for patients with metastatic cancer, as measured by Relative Dose Intensity. The trial involves a number of other outcomes, including tumor response, survival, toxic side effects, patient quality of life and patient experience An economic evaluation adopting a societal perspective will be conducted, in order to estimate those health. care resources’ used. A parallel process evaluation will be conducted to describe implementation of the intervention.DiscussionIf the CAPRI program does improve treatment delivery, the evidence on its economic impact will offer important knowledge for health decision-makers, helping develop new follow-up services for patients receiving oral chemotherapy and/or targeted therapy. The process evaluation will determine the best conditions in which such a program might be implemented.Trial registrationNCT 02828462. Registered 29 June 2016.
BMJ | 2016
Philippe Loirat; Marie Ferrua; Benoît Lalloué; Aude Fourcade; Etienne Minvielle
The introduction of the Hospital Value Based Purchasing (HVBP) programme, as shown recently by Jose F Figueroa and colleagues,1 did not improve 30 day mortality of Medicare beneficiaries admitted to US hospitals for three incentivised conditions. We agree with the authors’ conclusion that an “appropriate mix of quality metrics and incentives to improve patient outcomes” has yet …
European Journal of Cancer | 2015
Anne Girault; Marie Ferrua; Benoît Lalloué; Claude Sicotte; Aude Fourcade; Fatima Yatim; Guillaume Hébert; Mario Di Palma; Etienne Minvielle
Journal de gestion et d'économie médicales | 2015
Marie Ferrua; Aude Fourcade; Benoît Lalloué; Anne Girault; Shu Jiang; Philippe Loirat; Etienne Minvielle
Journal de gestion et d'économie médicales | 2012
Shu Jiang; Mélanie Couralet; Anne Girault; Aude Fourcade; Marc LeVaillant; Philippe Loirat; Etienne Minvielle; U. Eryuruk; Pol Leclercq
Journal of Clinical Oncology | 2016
Fatima Yatim; Marie Ferrua; Aude Fourcade; Mario Di Palma; Etienne Minvielle
Journal of Clinical Oncology | 2017
Anne Girault; Marie Ferrua; Aude Fourcade; Guillaume Hébert; Jonathan Lapointe; Claude Sicotte; Muriel Mons; Sophie Beaupère; Naïma Mezaour; François Lemare; Anne Montaron; Michel Ducreux; Charles Guepratte; Mario Di Palma; Etienne Minvielle
Journal de gestion et d'économie médicales | 2017
Aude Fourcade; Benoît Lalloué; Marie Ferrua; Anne Girault; Philippe Loirat; Étienne Minvielle
Annals of Oncology | 2017
Marie Ferrua; M. Di Palma; François Lemare; Aude Fourcade; Benoît Lalloué; F. Daumas Yatim; M. Guillet Lacaze; Etienne Minvielle